Dexeus Mujer implements NIPT universally as a screening method to improve the sensitivity of chromosomal abnormality detection
Dexeus Mujer has changed the way it screens for chromosomal abnormalities in the first trimester. All patients are now offered the option of a non-invasive test that analyses foetal DNA. This is one of the most accurate and reliable non-invasive prenatal screening tests (NIPT) on the market.